Results 171 to 180 of about 141,024 (211)

Platelet-like particles released from Ebola virus-infected megakaryocytic cells behave like virus-like particles. [PDF]

PLoS Pathog
Kuroda M, Halfmann PJ.
europepmc   +1 more source

Investigating the spatiotemporal links between the EVD outbreaks in Likati (2017) and Eastern DRC (2018-2020): a retrospective transdisciplinary study. [PDF]

BMC Infect Dis
Park SJ, Nkuba-Ndaye A, Muhindo-Wema K, Mulopo-Mukanya N, Kavira-Muhindo MA, Kwizera-Sendegeya J, Muloki-Nsele M, Morisho-Mungeleza M, Morisho-Mwanabiningo N, Mukadi-Bamuleka D.   +9 more
europepmc   +1 more source

SWOT analysis of Mpox surveillance in high-burden districts in Uganda, February-March 2025. [PDF]

One Health Outlook
Mutesi C, Migisha R, Kwesiga B, Gidudu S, Bulage L, Lukabwe I, Atim D, Ario AR.   +7 more
europepmc   +1 more source

Effect of the time of day for vaccination on the immune response to Ebola Virus Disease vaccines: A modeling study from PREVAC randomized trial. [PDF]

PLoS Negl Trop Dis
Kpetigo AD, Alexandre M, Camara A, Beavogui A, Doumbia S, Kieh M, Leigh B, Sow S, Wittkop L, Soutthiphong AA, Berry IM, Fleck S, Akoo P, Hamze B, Watson-Jones D, Kuhn JH, Greenwood B, Richert L, Yazdanpanah Y, Lévy Y, Thiébaut R, Prague M, PREVAC Study Team, Lhomme E.   +23 more
europepmc   +1 more source

Strengthening health system resilience during COVID-19: a qualitative study of national-level decision-makers in Guinea and Sierra Leone. [PDF]

BMJ Glob Health
Fischer HT, Mbawah AK, Geurts B, Baldé H, Menelik-Obbarius S, Kaba I, Stein K, Merhi V, Dikmen-Bahr T, Dumbuya K, Diaconu V, Johann S, Weishaar H, Babawo L, Delamou A, El Bcheraoui C.   +15 more
europepmc   +1 more source

Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation. [PDF]

BMJ Open
Hartley CD, Linderman S, Fashina T, Ward L, Drews-Botsch C, Pratt C, Kuthyar S, Fernandes AF, Huang Y, Choo C, Nguyen N, Carag J, Morgan J, Kraft CS, Hewlett A, Brett-Major D, Schieffelin JS, Garry RF, Grant D, Justin GA, Conrady CD, Smith JR, Hayek BR, Balendra S, Acharya N, Doan T, Legand A, Formenty P, Zeng X, Conteh I, Vandy MJ, Harrison-Williams L, Mustapha J, Koroma Z, Wiley MR, Crozier I, Mwanza JC, Shantha JG, Ahmed R, Yeh S, SMILE and EVICT-VR Investigator Study Groups.   +40 more
europepmc   +1 more source

Progressive Development of a New Tool for Rapid Thematic Analysis of Community Perceptions and Concerns During Health Emergencies. [PDF]

Glob Health Sci Pract
Earle-Richardson G, Nestor C, Prue CE.
europepmc   +1 more source

Inactivation of Ebola, Nipah, and Lassa viruses in tissue using neutral buffered formalin, MagMAX lysis/binding solution, or TriPure isolation reagent. [PDF]

Sci Rep
Davies KA, Welch SR, Harcourt BH, Spiropoulou CF, Spengler JR.   +4 more
europepmc   +1 more source

Incidence and predictors of Sudan ebolavirus transmission among contacts in Uganda in 2022: a retrospective cohort study. [PDF]

BMC Public Health
Mulongo M, Matovu JKB, Lubaale YAM, Olupot-Olupot P.   +3 more
europepmc   +1 more source

Assessing rapid response mobile laboratory (RRML) capacities in Europe and Africa to improve One Health disease surveillance activities and pandemic preparedness across two continents. [PDF]

One Health Outlook
Trojnacki A, Nguinkal JA, May J, Rainer K, Duscher GG, Winkelmayer L, Ungureanu A, Jaho E, Vlachostergiou A, Suciu G, Stalidi C, Marcu L, Annus H, Kamdron K, Aasamäe A, Groschup M, Dietze K, Knauf S, Keller M, Mellou K, Politi L, Neubauer G, Ignjatović D, Melo AM, Peham JR, Affara M, Gehre F.   +26 more
europepmc   +1 more source